Chronic kidney disease and kidney health care status: the healthy life in Suriname (HeliSur) study

被引:0
作者
Rani Nannan Panday
Yentl Haan
Frederieke Diemer
Amar Punwasi
Chantal Rommy
Ingrid Heerenveen
Gert A. van Montfrans
Lizzy M. Brewster
机构
[1] Academic Medical Center,Department of Internal Medicine
[2] Academic Hospital of Paramaribo,Department of Cardiology
[3] Academic Hospital of Paramaribo,Department of Internal Medicine
[4] Surrenal Dialysis Center,Faculty of Medicine
[5] Anton de Kom University,undefined
[6] Nefrosur Medical Centre,undefined
[7] Amsterdam Institute for Global Health and Development,undefined
[8] Creatine Kinase Foundation,undefined
来源
Internal and Emergency Medicine | 2019年 / 14卷
关键词
Cardiovascular risk factors; Chronic kidney disease; Renal replacement therapy; Low- and middle-income countries; Kidney health care;
D O I
暂无
中图分类号
学科分类号
摘要
The high cardiovascular risk burden in low- and middle-income countries is expected to lead to an explosive increase in chronic kidney disease (CKD). However, population data on CKD from these countries are scarce. Therefore, we assessed kidney health in Suriname. In the Healthy Life in Suriname (HeliSur) study, a random sample of the adult population, we collected data with standardized questionnaires, physical examination, and blood and urine samples analysed in a central laboratory. Prevalent CKD was graded with KDIGO guidelines. In addition, we assessed national data on prevalent renal replacement therapy (RRT), estimated the future need for RRT, and evaluated national kidney health work force and policies. We include 1117 participants (2.0‰ of the population), 63% women, 40% of African ancestry and 43% of Asian ancestry, with a mean age of 42.2 (SE 0.4) years. Blood pressure is elevated in 72% of the participants, 26% have diabetes or prediabetes, and 78% are obese or overweight. The prevalence of CKD is 5.4%, and around 0.3% have kidney failure, translating to approximately 1500 patients nationally (2690 per million population, pmp), with currently 516 patients (920 pmp) on dialysis. Based on the participants from the random population sample in CKD stage G3 or G4, we estimate that 6750–10,750 pmp may develop kidney failure within the next 10 years. However, specialized kidney health workforce is currently very limited, and specific national or local policies for CKD management are lacking. Since the large majority of the general population has one or more risk factors for CKD including elevated blood pressure, urgent action is needed to strengthen kidney health care and prevent a catastrophic rise in need for RRT in the coming years.
引用
收藏
页码:249 / 258
页数:9
相关论文
共 275 条
[1]  
Stanifer JW(2013)Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 Lancet 2015 117-171
[2]  
Muiru A(2017)(NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants Lancet 389 37-55
[3]  
Jafar TH(2016)(NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants Lancet 387 1513-1530
[4]  
Patel UD(2016)Chronic kidney disease in low- and middle-income countries Nephrol Dial Transplant 31 868-874
[5]  
Neuen BL(2017)Chronic kidney disease and the global NCDs agenda BMJ Glob Health 2 e000380-1140
[6]  
Chadban SJ(2017)Hypertension and cardiovascular risk profile in a middle-income setting: the HELISUR study Am J Hypertens 30 1133-229
[7]  
Demaio AR(2017)Impact of creatinine methodology on glomerular filtration rate estimation in diabetes World J Diabetes 8 222-443
[8]  
Johnson DW(2015)A risk assessment of the Jaffe vs enzymatic method for creatinine measurement in an outpatient population PLoS One 10 e0143205-238
[9]  
Perkovic V(2009)First morning voids are more reliable than spot urine samples to assess microalbuminuria J Am Soc Nephrol 20 436-1334
[10]  
Diemer FS(2012)Does stage III chronic kidney disease always progress to end-stage renal disease? A ten-year follow-up study Scand J Urol Nephrol 46 232-28